Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials

…, DM Fisher, T Roth, C Scott, G Birznieks… - The Lancet, 2009 - thelancet.com
Background Circadian rhythm sleep disorders are common causes of insomnia for millions
of individuals. We did a phase II study to establish efficacy and physiological mechanism, …

[PDF][PDF] The Finland–United States investigation of non–insulin-dependent diabetes mellitus genetics (FUSION) study. I. An autosomal genome scan for genes that …

…, K Kohtamäki, P Chines, J Balow, G Birznieks… - The American Journal of …, 2000 - cell.com
We performed a genome scan at an average resolution of 8 cM in 719 Finnish sib pairs with
type 2 diabetes. Our strongest results are for chromosome 20, where we observe a weighted …

Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs

…, K Kohtamaki, P Chines, G Birznieks… - Proceedings of the …, 1999 - National Acad Sciences
We are conducting a genome scan at an average resolution of 10 centimorgans (cM) for type
2 diabetes susceptibility genes in 716 affected sib pairs from 477 Finnish families. To date, …

[HTML][HTML] Efficacy and safety of tradipitant in patients with diabetic and idiopathic gastroparesis in a randomized, placebo-controlled trial

…, A Dahal, MS Keefe, C Xiao, G Birznieks… - Gastroenterology, 2021 - Elsevier
Background & Aims Treatments are needed for gastroparesis; antagonists of tachykinin
receptor 1 (TACR1, also called NK1R) can reduce symptoms of nausea and vomiting. We …

[HTML][HTML] Correlation of age-of-onset of Atopic Dermatitis with Filaggrin loss-of-function variant status

…, C Xiao, J Wang, C Polymeropoulos, G Birznieks… - Scientific Reports, 2020 - nature.com
The genetic background of Atopic Dermatitis (AD) with chronic pruritus is complex. Filaggrin
(FLG) is an essential gene in the epidermal barrier formation s. Loss-of-function (LOF) …

[PDF][PDF] The Finland–United States investigation of non–insulin-dependent diabetes mellitus genetics (FUSION) study. II. An autosomal genome scan for diabetes …

…, E Trager, PP White, J Balow, G Birznieks… - The American Journal of …, 2000 - cell.com
Type 2 diabetes mellitus is a complex disorder encompassing multiple metabolic defects.
We report results from an autosomal genome scan for type 2 diabetes–related quantitative …

[HTML][HTML] Identification of potential COVID-19 treatment compounds which inhibit SARS Cov2 prototypic, Delta and Omicron variant infection

…, BP Przychodzen, V Koprivica, G Birznieks… - Virology, 2022 - Elsevier
Recurrent waves of COVID19 remain a major global health concern. Repurposing either
FDA-approved or clinically advanced drug candidates can save time and effort required for …

[BOOK][B] CGI Programming with Perl: Creating Dynamic Web Pages

S Guelich, S Gundavaram, G Birznieks - 2000 - books.google.com
Programming on the Web today can involve any of several technologies, but the Common
Gateway Interface (CGI) has held its ground as the most mature method--and one of the most …

Delayed sleep phase disorder risk is associated with absenteeism and impaired functioning

SMW Rajaratnam, L Licamele, G Birznieks - Sleep Health, 2015 - Elsevier
Study objectives The absence of a screening questionnaire for delayed sleep phase
disorder (DSPD) remains a barrier to its detection and subsequent clinical evaluation. We …

[HTML][HTML] Tasimelteon safely and effectively improves sleep in Smith–Magenis syndrome: a double-blind randomized trial followed by an open-label extension

…, K Kite, SP Smieszek, C Xiao, SH Elsea, G Birznieks… - Genetics in …, 2021 - Elsevier
Purpose To assess the efficacy of tasimelteon to improve sleep in Smith–Magenis syndrome
(SMS). Methods A 9-week, double-blind, randomized, two-period crossover study was …